IDENTIFICATION OF BACTERIA CAUSING NECROTIC PULP WITH 16S rRNA GENE POLYMERASE CHAIN REACTION AND ANTIBIOTIC RESISTANCE TESTING AT THE DENTAL HOSPITAL IN SEKELOA, BANDUNG, INDONESIA by Rostinawati, Tina et al.
Vol 10, Issue 6, 2017
Online - 2455-3891 
Print - 0974-2441
IDENTIFICATION OF BACTERIA CAUSING NECROTIC PULP WITH 16S rRNA GENE 
POLYMERASE CHAIN REACTION AND ANTIBIOTIC RESISTANCE TESTING AT THE DENTAL 
HOSPITAL IN SEKELOA, BANDUNG, INDONESIA
TINA ROSTINAWATI*, SULISTIYANINGSIH HADISOEBROTO, YOPPI ISKANDAR, PRASETYO HADI NUGROHO, 
AUDRIA AMANDA TARA
Department of Biological Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Jatinangor, Indonesia. Email: t_rostinawati@unpad.ac.id
Received: 28 February 2017, Revised and Accepted: 27 March 2017
ABSTRACT
Objective: This study aims to identify the bacteria that cause necrotic pulp in teeth of dental patients and test resistance of the bacteria found to 
antibiotics.
Methods: Bacteria were taken with paper points that were inserted into the root canal of patients at the Dental Hospital of the Faculty of Dentistry, 
Universitas Padjadjaran, Sekeloa, Bandung. Bacteria were cultured and Gram-stained. Bacterial DNA was isolated to be identified by polymerase chain 
reactions 16S rRNA method against known sequences of bacterial DNA. Then, identified bacteria were tested for antibiotic resistance to tetracycline 
(30 µg), clindamycin (2 µg), amoxicillin (10 µg), and ampicillin (10 µg).
Results: The 16s rRNA gene fragment of the main bacterium found was in 98% homology with 16S rRNA gene database in http://blast.ncbi.nlm.
nih.gov, i.e., Pseudomonas aeruginosa and Acinetobacter schindleri. The results from inhibition zone of each antibiotic were 20.12 mm, 8.97 mm, 
8.12 mm, and 8.03 mm for tetracycline, clindamycin, amoxicillin, and ampicillin, respectively, to P. aeruginosa. While inhibition zone of tetracycline to 
A. schindleri was 37.7 mm.
Conclusion: Based on the study results, P. aeruginosa from patients with necrotic pulp samples were resistant to clindamycin, amoxicillin, ampicillin, 
and decreased activity to tetracycline. While Acinetobacter schindleri was still sensitive to tetracycline.
Keywords: Identification of bacteria, Necrotic pulp, Polymerase chain reaction of 16S rRNA gene, Sequencing, Antibiotic resistance test.
INTRODUCTION
The necrotic pulp is found in a non-vital tooth that is damaged throughout 
the pulp (root canals), which is generally caused by microorganisms that 
cause cavities. Inflammatory damage will occur if the microorganism 
cause symptoms and clinical signs in the host. Bacteria are a major 
causal factor in the development of necrotic pulp and periapical disease 
[1]. Microorganisms get into the pulp in several ways, the most common 
is an open pit cavity due to dental caries. In addition, microorganisms 
can reach the pulp due to trauma or mechanical injury, gum sulcus, and 
through the bloodstream [1]. Based on data from the Household Health 
Survey (Household) in 2004 by the Ministry of Health of the Republic of 
Indonesia, the prevalence of dental caries in the population is 90.05% 
[2]. Pulp and periapical diseases are caused by several types of bacteria, 
especially anaerobic bacteria, such as Osenellauli, Eikenellacorrodens, 
Porphyromonas endodontalis, Peptostreptococcus, Bakterioides, 
Eubacterium, Staphylococcus aureus, and Fusobacterium nucleatum 
[3]. One treatment of necrotic pulp includes root canal irrigation with 
antibiotics. The solution contained the antibiotic is used to dissolve the 
debris resulting from root canal preparation and also to disinfect the 
root canal. Irrigation solution commonly used in dentistry included the 
class of antibiotics such as mixture of tetracycline and disinfectants 
and tetraclean, containing a mixture of doxycycline 500 mg/ml with 
propylene glycol [4,5]. The ability of the irrigation solution to kill 
bacteria had become more limited, concomitant with the discovery of 
genes encoding tetracycline resistance in mouth bacteria, i.e., tet (M), tet 
(O), tet (Q), tet (W), tet (32), and tet (A) [6]. A large number of patients 
with necrotic pulp were recorded, around 122,467 and a total of 
234,083 cases of complaints of oral disease in Indonesia. This indicated 
that recurrent therapeutic treatment is required and a possibility of 
antibiotic resistance in bacteria that cause necrotic pulp [7]. The fact 
that high rates of necrotic pulp are necessary to attempt the detection 
of bacteria causing the infection and the sensitivity to antibiotics that 
have not been reported so far in Indonesia’s Dental Hospital. This study 
was conducted to determine the types of microorganisms that cause 
necrotic pulp and resistance patterns of these microorganisms to 
antibiotics for therapeutic effectiveness.
METHODS
The Ethical Committee approval was provided by Medical Faculty of 
Universitas Padjadjaran in Indonesia, Code No:041/UN6.C1.3.2/KEPK/
PN/2016.
Sampling bacteria in necrotic pulp
Samples were taken by one of the Hospital Dental Faculty of 
Dentistry, University of Padjadjaran, Sekeloa, Bandung. Samples 
were taken from the plaque of patients with necrotic pulp using 
sterilized equipment. Plaque samples were then inserted into a 
transport medium containing sterilized trypticase soy broth (TSB). 
The samples were then taken to the Laboratory of Microbiology, 
Faculty of Pharmacy, University of Padjadjaran, and incubated at 
37°C for 18-24 hrs.
Isolation of bacteria causing necrotic pulp
A suspension of the incubated bacteria was then transferred to 
trypticase in soy agar (TSA) with the incised plate method. A total of 
30 ml of sterile TSA media was poured into a Petri dish and then allowed 
to solidify. A total of 1 loopful bacterial suspension taken from TSB 
medium and then smeared onto TSA media that had been overbooked. 
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The media was incubated at 37°C for 18-24 hrs. Isolation was done by 
moving each growing bacterial colonies onto new TSA.
Morphological observation of bacteria
Observations were made with a microscope to see the colors, shapes, 
edges, and the elevation of bacterial colonies.
Gram-staining of bacteria
A total of 1 loopful bacteria was suspended in sterile distilled water and 
then was fixed on a clean glass slide. The spread of bacteria was flooded 
with two drops of carbolic gentian violet, and then was allowed to sit 
for 1 minute. Excess dye was removed, then the slide was rinsed with 
running water. The spread of bacteria then was flooded with two drops 
of Lugol 2%, then was allowed to sit for 1 minute. Excess Lugol was 
discarded, then smear was faded using 95% alcohol. After rinsing with 
running water, the smear was flooded with 2-3 drops of 1% fuchsin, 
then was allowed to sit for 1 minute. Excess dye was removed, then 
was rinsed with water and was dried using a filter paper. The smear 
was covered with emersion oil and then was observed under a light 
microscope under 1000× magnification.
Isolation of bacteria chromosomal DNA
Isolation procedure followed the protocol of the PROMEGA® Genomic 
DNA Purification System. Briefly, a total of 1 ml of the bacterial 
suspension in a liquid medium was put in a 1.5 ml microtube. The tube 
was centrifuged for 2 minutes at 16,000 ×g to pellet the bacterial cells. 
The supernatant in the tube was removed, the cell pellet resuspended 
in 480 µl of 50 mM ethylenediaminetetraacetic acid. Then, 120 µl of the 
lysozyme (10 mg/ml) was added to break down the cell walls of bacteria. 
The tube was incubated at 37°C in a water bath for 60 minutes. Thereafter, 
the tube was centrifuged at 16,000 ×g for 2 minutes at room temperature. 
The supernatant was discarded, then 600 µl of nuclei lysis solution was 
added and pipetted until the entire cell pellet was homogenized. The 
tube was incubated at 80°C for 5 minutes in a water bath, then was 
cooled to room temperature. To eliminate RNA, 3 µl of RNase Solution 
(40 µl/ml) was added until the solution was homogeneous and was 
incubated at 37°C for 30 minutes. The tube was cooled down to room 
temperature, then 200 µl of protein precipitation solution was added. 
The solution was homogenized by vortexing for 20 seconds to mix the 
lysate of cells with the protein precipitation solution. The solution was 
then incubated on ice for 5 minutes and centrifuged at 16,000 ×g for 
3 minutes. The supernatant was transferred to a new 1.5 ml microtube to 
which had been added 600 µl of isopropanol. The supernatant solution 
with isopropanol was homogenized by inverting the tube gently. The 
tube was centrifuged at 16,000 ×g for 2 minutes. The supernatant 
was discarded, the tube was reversed and drained onto the tissue. The 
DNA pellet was added 600 µl of 70% ethanol, and shaken to clean the 
homogeneous DNA pellets. The tube was centrifuged at 16,000 ×g again 
for 2 minutes, then ethanol was removed and slowly dried from the tube 
using tissue without the precipitated DNA pellets. DNA pellets were 
allowed to stand for 10-15 minutes, then resuspended in 100 µl of DNA 
rehydration solution. The solution was then stored at a temperature of 
−20°C as a DNA sample. The obtained chromosomal DNA was detected 
by 1% agarose gel electrophoresis and visualized on a ultraviolet (UV) 
detector. Electrophoresis was performed for 40 minutes with a flow of 
electrical current of 100 V. The marker used as a DNA marker had a size 
of 1 kb (1000 pb).
Amplification of 16S rRNA gene
The 16S rRNA gene amplification was performed by polymerase 
chain reaction (PCR). Primers used in the amplification of 16S 
rRNA gene were 1492R (5’ GGTTACSTTGTTACGAC 3’) and 27F 
(5’ AGAGTTTGATCMTGGCTCAG 3’). Components of PCR was 
consisted of 2 µl of 15 μM primer 1492R; 2 µl of 15 μM primer 27F; 1 
µl of 10 mM dNTP; 6 µl of ×10 PCR buffer (containing 20 mM MgCl2); 
0.4 µl of Taq polymerase 5 U/ml; and 2 µl DNA template and added 
to 50 µl of nuclease-free water. All components were inserted into 
200 µl microtubes and homogenized. The tubes were inserted into the 
thermocycler. Temperature and time amplification stage was set with an 
initial denaturation 94°C for 5 minutes. Cycles consisted of denaturation 
step at 94°C for 1 minute, annealing 55°C for 1 minute, elongation of 
DNA fragments 72°C for 1 minute, the reaction was carried out for as 
many as 30 cycles. Post elongation after 30 cycles of DNA fragment 
was at 72°C for 10 minutes. The result of 16S rRNA gene amplification 
was also detected by 1% agarose gel electrophoresis with a 1 kb DNA 
size marker and visualized on a UV detector. Electrophoresis was also 
performed for 40 minutes with a flow of electrical current of 100 V.
Determination of the sequence of 16S rRNA gene fragment
Determination of 16S rRNA gene sequence was performed in First BASE 
Laboratory, Selangor, Malaysia. Analysis of the results was performed 
by Basic Local Alignment Search Tool (BLAST) nucleotide sequence of 
16S rRNA gene sequencing results with the database available on the 
site http://blast.ncbi.nlm.nih.gov.
Resistance test
Bacteria samples from the patient were assayed for resistance to 
some common antibiotics, i.e., tetracycline (30 µg), clindamycin 
(2 µg), amoxicillin (10 µg), and ampicillin (10 µg). Muller-Hinton agar 
liquid media (temperature 40-50°C) was added to the Petri dish that 
already contained a bacterial suspension equivalent to a 0.5 McFarland 
standard. Then, the mixture was homogenized and allowed to condense. 
The resistance test was performed by using 10 µl antibiotic containing 
paper disk placed on the agar medium containing the bacteria. The Petri 
plate was closed and incubated at 37°C for 18-24 hrs. The inhibition 
zone formed was measured using calipers.
RESULTS
Isolation of bacteria from sample
Bacteria from the necrotic pulp patient was suspended in the sterile 
TSB media. The result of bacteria growth in sterile TSB media is given 
in Fig. 1. Furthermore, bacteria were grown on sterile TSA media when 
it was re-incubated in solid media (Fig. 2). The observation of bacteria 
colonies showed that they were gray-green with a round shape, 
stood out and had flat edges in sample 1. Otherwise, in sample 2, the 
morphology of colonies had a spherical shape (cocci) as well as the 
edges had an irregular and flat elevation.
Gram-staining of bacteria
The bacteria isolated were Gram-negative (Fig. 3). In sample 1, the 
bacteria were rod-shaped. In sample 2, there were coccus-shaped 
bacteria.
Isolation of chromosomal DNA bacteria
The results of chromosomal DNA visualization can be seen in Fig. 4, 
showing one band for each sample with size more than 10,000 bp. Most 
bacteria have a chromosome with a size of more than 4.6 Mb.
Amplification of 16S rRNA gene by PCR
The visualization of 16S rRNA gene amplification results for samples 
1 and 2 showed one band of DNA with size about 1500 bp (Fig. 5). The 
Fig. 1: Result of planting bacteria sample on trypticase soy agar 
media
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length of 16S rRNA gene fragments was suitable with the length of DNA 
amplified using primers 27F and 1492R.
The results of 16S rRNA gene sequencing using the 27F primer showed 
a 1042 bp fragment for sample 1 and 995 bp fragment for sample 
2 (Fig. 5). Results of DNA sequence alignment of 16S rRNA gene 
fragment to the database contained on the site http://blast.ncbi.nlm.
nih.gov BLAST showed that the samples of the bacteria patients with 
necrotic pulp had values of similarity with Pseudomonas aeruginosa 
and Acinetobacter schindleri, respectively, for sample 1 and 2, with 98% 
accuracy for both bacteria.
Resistance test
The result of P. aeruginosa resistance test can be seen in Table 1 was 
then compared with the manual resistance test that CLSI in 2007 [8]. 
Based on the result of resistance test, P. aeruginosa from a patient with 
necrotic pulp sample was resistant to clindamycin, amoxicillin, and 
ampicillin, with decreasing activity in tetracycline, which can be seen 
from the result of inhibition zone diameters for the four antibiotics for P. 
aeruginosa (Table 1). The activity test of antibiotics against A. schindleri 
only used tetracycline which had activity with an inhibition zone of 
37.7 mm (figure not shown).
DISCUSSION
The genetic identification of P. aeruginosa and A. schindleri was 
also supported by the bacterial morphology test. The morphology 
observation of P. aeruginosa included rod-shaped bacteria, a Gram-
negative and greenish gray colony while A. schindleri had its characteristic 
morphology, i.e., cocci, irregular and flat elevation. P. aeruginosa as a 
potential cause of necrotic pulp has not been previously reported. Root 
canal infections are dominated by polymicrobial anaerobic bacteria. The 
most microorganisms commonly found are Gram-negative anaerobic 
rods, anaerobic Gram-positive cocci, Gram-positive anaerobic and 
facultative rods, species Lactobacillus sp., Gram-positive facultative and 
Streptococcus species [5]. P. aeruginosa is considered to be a facultative 
anaerobe because it can live in conditions of total oxygen depletion [9]. 
While the Acinetobacter genus is seen as strictly aerobic, but there is 
species of Acinetobacter that is anaerobic facultative, i.e., Acinetobacter 
baumannii. Otherwise in this research found A. schindleri that was 
also classified as a definite or probable pathogen in four cases (80%) 
with the potential to cause severe opportunistic infections [10]. Hence, 
A. schindleri is also the bacteria causing necrotic pulp that has not been 
previously reported. A. schindleri, lately described in 2001, initially it 
could be ignored as opportunistic pathogens because its ordinarily 
identification as phenotypic approach could not be done, due to its 
absence in the databases [11]. Even though Acinetobacter species 
is low phatogenic potential, they have increasingly been discovered 
as opportunistic pathogens particularly in immunocompromised 
patients and patients hospitalized in intensive care units [12]. 
Otherwise, there were many species of bacteria that were often 
detected in an infection in the pulp, not included Pseudomonas and 
Acinetobacter species, such as Dialister, Capnocytophage, Actinomyces, 
Porphyromonas, Eikenella, Pseudoramibacter, Corynebacterium, 
Tannerella, Aggregatibacter, Filifactor, Lactobacillus, Prevotella, 
Eubacterium, Fusobacterium, Mogibacterium, Campylobacter, 
Propionibacterium, Synergistes, Eggerthella, Pyramidobacter, 
Oise nella, Jonquetella, Bifidobacterium, Catonella, Solobacterium, 
Lactobacillus, Veillonella, Neisseria, Parvimonas, Streptococcus, 
Megasphaera, Peptostreptococcus, Enterococcus, Anaeroglobus, 
Finegoldia, Granulicatella, Peptoniphilus, Anaerococcus, Gamella, 
and Treponema [13]. For pathogenicity compared to A. schindleri, 
Fig. 2: Result of replanting single colony of bacteria samples on 
trypticase soy agar media
Fig. 3: Result of Gram-staining bacterial isolate
Fig. 4: Result of chromosomal DNA isolation
Fig. 5: Result of amplification of gene encoding bacterial 16S 
rRNA. Sample 1: Pseudomonas aeruginosa,  
sample 2: Acinetobacter shindleri, M: DNA marker
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P. aeruginosa is more frequently associated with causing human 
infection; however, it naturally exists in the environment [14]. The 
bacterium is also regarded as an opportunistic pathogen, primarily 
causing nosocomial infections in immunocompromised patients [15,16].
Based on resistance testing, the four antibiotics used were no longer 
effective to treat P. aeruginosa. Unfortunately, currently, tetracycline 
and amoxicillin are still in use in the solution irrigation in the treatment 
of necrotic pulp [4]; the effectiveness of the use of these antibiotics 
against infection in the necrotic pulp caused by P. aeruginosa needs to 
be evaluated. In a previous study, bacterial tooth root was still sensitive 
to amoxicillin and ampicillin; however, the sensitivity of bacterial 
tooth root to tetracycline and clindamycin was decreased [17]. 
P. aeruginosa has become a major cause of nosocomial bacterial 
infections especially in immunosuppressed patients who need 
prolonged hospitalization [18]. It had been reported, P. aeruginosa 
isolates, samples were obtained from patients who were hospitalized 
for more than 1 week duration, that was from a tertiary care hospital 
in Punjab, India, had become resistance to cephalosporins (60%), 
cefotaxime (75%), ceftriaxone (63%), ceftazidime and amikacin 
(41.5%), gentamicin (79%), ciprofloxacin (73.2%), piperacillin 
(44%), and lower resistance was seen to imipenem (3.7%) [19]. From 
another result of P. aeruginosa isolates had shown that imipenem 
and amikacin were the most effective antibiotics [20]. Otherwise, the 
other antibiotics had performed the resistance to P. aeruginosa were 
ciprofloxacin (32%), β-lactamase inhibitor (piperacillin) (34%), third 
generation (ceftazidime) (36%), netilmicin (40%), and gentamicin 
(48%) [20]. Antibiotic resistant - P. aeruginosa are strongly associated 
with nosocomial infections, that are a worldwide health concern due 
to the increasing development of multidrug resistance (MDR) strains 
(i.e. resistance to at least three antibiotics) [21]. Various therapeutic 
challenges exist with MDR P. aeruginosa due to the limit of effective 
treatment strategies. The current literature strongly associates 
inadequate empirical treatment with increased rates of mortality 
and morbidity [22]. P. aeruginosa is intrinsically resistant to various 
antibiotics due to a low permeability of its the outer membrane, which 
acts as a selective barrier [23]. Resistance mechanisms of P. aeruginosa 
include producing the enzyme that inactive antibiotics, an antibiotics 
efflux system, and decreased the permeability of the outer membrane 
bacteria [24]. For A. schindleri, it is said to have resistance if it has a 
diameter of 1.8 cm below the inhibitory zone [8]. Thus, it was concluded 
that the antibiotic tetracycline is effectively used as a treatment for 
necrotic pulp caused by A. schindleri. Studies by Dortet et al. [10] the 
strains of A. schindleri showed they were susceptible to penicillin, 
cefuroxime, ceftazidime, cefepime, and imipenem, whereas other 
β-lactams performed a variable activity. They were similar susceptible 
to aminoglycosides, quinolones, chloramphenicol, tetracycline, and 
colistin. Almost all strains were resistant to fosfomycin (80%) and 
trimethoprim (70%), while they were variably susceptible to rifampin, 
sulfonamide, and furans [10].
CONCLUSION
P. aeruginosa and A. schindleri were Gram-negative bacteria founded 
in necrotic pulp teeth in patients in Dental Hospital, Sekeloa, Bandung, 
Indonesia. Based on this data, the necrotic pulp can also be caused by 
opportunistic bacteria.
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